Caption Management, LLC Aerie Pharmaceuticals Inc Call Options Transaction History

Caption Management, LLC

  • $6.13 Billion
  • Q2 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2021

Feb 11, 2022
SELL
$7.02 - $13.33 $256,931 - $487,878
-36,600 Closed
0 $0
Q3 2021

Nov 12, 2021
SELL
$11.32 - $16.63 $1.85 Million - $2.72 Million
-163,400 Reduced 81.7%
36,600 $417,000
Q4 2019

Feb 13, 2020
BUY
$17.72 - $25.1 $1.33 Million - $1.88 Million
75,000 Added 60.0%
200,000 $4.83 Million
Q3 2019

Nov 14, 2019
BUY
$18.41 - $28.0 $2.3 Million - $3.5 Million
125,000 New
125,000 $2.4 Million

Others Institutions Holding AERI

# of Institutions
3
Shares Held
2.4M
Call Options Held
0
Put Options Held
0
View Full List

About AERIE PHARMACEUTICALS INC

AERI Quotes by TradingView
  • Ticker AERI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,390,500
  • Description
  • Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...
More about AERI
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email